Recent Company News

• 11:09 AM ET Jul 23, 2025
  

  HHS adopts ACIP recommendation to remove thimerosal from remaining influenza vaccines

• 09:49 PM ET Jul 17, 2025
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 01:14 PM ET Jun 26, 2025
  

  CDC ACIP votes 6-0-1 to recommend routine annual influenza vaccination

• 08:50 AM ET Jun 25, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 01:04 AM ET Jun 26, 2025
  

  Valneva announces exclusive vaccine marketing and distribution agreement for Germany with CSL Seqir (€2.35, 0.00)

• 05:15 PM ET Jun 24, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:38 PM ET Jun 24, 2025
  

  NICE recommends Ligand's Filspari to treat primary IgA nephropathy ($118.22, 0.00)

• 11:13 AM ET Jun 24, 2025
  

  CDC ACIP web updates suggest June meeting proceeding; another meeting in September/October timeframe